By Leader Health Editorial Team. Medically Reviewed by Stephen Ratcliff MD, Chief Medical Officer. Last reviewed: 2026-05-29.
By Leader Health Editorial Team. Medically Reviewed by Stephen Ratcliff MD, Chief Medical Officer. Last reviewed: 2026-05-29.
By Leader Health Editorial Team. Medically Reviewed by Stephen Ratcliff MD, Chief Medical Officer. Last reviewed: 2026-05-29.
Physician overview of PT-141: how bremelanotide works on the central nervous system, the evidence base, who it's appropriate for, and what to expect.
Physician overview of PT-141: how bremelanotide works on the central nervous system, the evidence base, who it's appropriate for, and what to expect.
Physician overview of PT-141: how bremelanotide works on the central nervous system, the evidence base, who it's appropriate for, and what to expect.
NAD+ Supplementation: What the Science Actually Shows About Oral Precursors vs. Injectable NAD+
NAD+ Supplementation: What the Science Actually Shows About Oral Precursors vs. Injectable NAD+
Stephen Ratcliff, MD
Chief Medical Officer
NAD+
Image is AI-generated and does not represent actual results.
Stephen Ratcliff, MD
Chief Medical Officer
NAD+
Image is AI-generated and does not represent actual results.
Stephen Ratcliff, MD
Chief Medical Officer
NAD+
Image is AI-generated and does not represent actual results.
Key takeaways
NAD+ is a coenzyme found in every cell, essential for energy metabolism and DNA repair. Levels decline with age. Oral NR and NMN raise blood NAD+ levels but the evidence for clinical outcomes in healthy adults is mixed. Injectable NAD+ has a stronger pharmacological argument for bioavailability but lacks its own large randomized trials. The honest framing is that the mechanism is real, the evidence is directional, and the value depends on physician-supervised use rather than DIY supplementation. Here is what we actually know.
A 2025 review in Nature Metabolism summarized the human clinical trial literature for NAD+ precursor supplementation in aging and concluded that despite robust preclinical signals, human trials have shown limited efficacy. That assessment landed because it was honest about something most NAD+ marketing was not. Raising a biomarker is not the same as improving health.
But the picture is more nuanced than that summary implies. The bioavailability difference between oral precursors and injectable NAD+ is real and matters clinically. Lumping them together obscures the actual question.
Here is what the evidence shows for each, where the honest gaps are, and how to think about NAD+ supplementation if you are evaluating it.
What NAD+ Is and Why It Matters
NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme — a small molecule that other proteins need to do their work. It is found in every cell of the body and is essential for three processes that matter for aging:
Energy metabolism. NAD+ is required for the chemical reactions that convert food into ATP, the molecule your cells use as energy.
DNA repair. The proteins that fix damaged DNA (particularly the PARP enzymes) use NAD+ as a substrate.
Sirtuin activation. The sirtuins are enzymes implicated in longevity pathways; they require NAD+ to function.
NAD+ levels decline with age. Studies in skeletal muscle and skin have reported tissue NAD+ concentrations 40–60% lower in older adults than in younger adults, though estimates vary by tissue and methodology. The plausible argument for supplementation is that restoring NAD+ levels could support the processes that depend on it. The honest question is whether raising blood NAD+ actually changes tissue NAD+, and whether tissue NAD+ changes translate into measurable clinical outcomes.
One small clarification worth making early: NAD+ is not a peptide, even though it is often marketed in the same category. It is a coenzyme. The distinction matters for how the evidence is interpreted.
Oral NR and NMN — What the Trials Actually Show
Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are the two most commonly used oral NAD+ precursors. Both raise blood NAD+ levels consistently in human trials. The clinical outcomes question is where the evidence gets thinner.
What has been shown in randomized trials:
Reliable increases in blood NAD+ levels at standard doses (300–1000 mg/day for NR; 250–1000 mg/day for NMN).
Modest improvements in measures of arterial stiffness in some studies — a marker of vascular aging.
Mixed evidence for cognitive function, physical performance, and recovery — some positive signals, some null results.
Generally good safety profile at studied doses.
What has not been clearly shown: large effects on the clinical outcomes that the marketing implies — energy, sleep, recovery, anti-aging measures. Individual response varies, and some users report meaningful changes while others report nothing.
The Nature Metabolism 2025 review was not wrong. The trial evidence for oral NR and NMN as anti-aging interventions in healthy adults is modest and directional, not conclusive. Anyone selling oral NAD+ precursors as proven anti-aging tools is overstating what the science currently supports. A simpler and cheaper option that also raises NAD+ is nicotinamide itself — worth knowing about even if it does not get the marketing attention.
Injectable NAD+ — The Pharmacology Argument
Injectable NAD+ — typically subcutaneous at 100–500 mg per dose, sometimes intravenous at 500–1500 mg per infusion — bypasses two limitations of oral supplementation. First, oral NAD+ precursors are subject to first-pass metabolism in the liver, where much of the compound is processed before reaching systemic circulation. Second, oral precursors require conversion to NAD+ inside cells, which happens efficiently in some tissues and less efficiently in others.
Direct subcutaneous NAD+ enters systemic circulation without requiring conversion in the gut or liver, though the specific pharmacokinetics in human tissue are still being characterized. Patient-reported outcomes in clinical practice tend to be more consistent than with oral preparations.
The honest limitation: injectable NAD+ does not have its own large randomized controlled trial database. The mechanism is plausible, the patient experience is often positive, and the safety profile in clinical use is good. Direct head-to-head trials comparing injectable NAD+ to oral NR/NMN to placebo for specific clinical outcomes do not exist at the scale we would like.
Cost is also worth being honest about. Oral NR/NMN supplements retail in the $30–60/month range. Physician-supervised injectable protocols are meaningfully more — typically several hundred dollars per month — which is worth weighing against the expected benefit.
How NAD+ and Glutathione Pair
NAD+ and L-glutathione are often used together in physician-supervised wellness protocols. The pairing is not arbitrary.
The mechanism is complementary. NAD+ supports the energy production happening in mitochondria. That energy production generates reactive oxygen species — free radicals — as a byproduct. Glutathione is the body's most important intracellular antioxidant, and it is what neutralizes those reactive oxygen species. Supporting energy production without supporting antioxidant defense leaves the mitochondria more exposed to oxidative damage.
There is no large trial proving the combination outperforms either alone. Clinically, the pairing is biologically coherent and widely used. We frame it that way to patients rather than overpromising synergy that has not been formally measured.
Side Effects and Practical Use
Both oral NR/NMN and injectable NAD+ are generally well tolerated.
Common with oral preparations: occasional GI upset, mild flushing at higher doses.
Common with injectable NAD+: mild injection site reactions, occasional flushing or mild nausea during or immediately after administration. IV administration at high doses can cause more pronounced flushing and chest tightness; subcutaneous administration at typical doses is considerably better tolerated.
Realistic expectations: most people who notice anything notice it gradually, over weeks. Anyone promising overnight transformation is selling marketing, not medicine.
How Leader Health Approaches This
At Leader Health, NAD+ supplementation is part of a physician-supervised wellness program — not a standalone purchase. We assess your baseline picture, set realistic expectations, monitor on a schedule, and pair NAD+ with the other tools (including L-glutathione) that mechanistically support what it is doing. If we do not think it is appropriate for you, we will say so.
If you have been considering NAD+ but are tired of marketing that overpromises, this is the conversation worth having.
References
Tan A, Mottillo EP, et al. NAD+ precursor supplementation in human ageing: a critical review of randomized clinical trials. Nat Metab. 2025. PMID: 41083806. nature.com/articles/s42255-025-01387-7.
Reiten OK, et al. Preclinical and clinical evidence for SIRT1 in the metabolism of aging — a critical review of NAD+ precursor supplementation. PMC10692436.
Yi L, et al. The Efficacy and Safety of β-Nicotinamide Mononucleotide (NMN) Supplementation in Healthy Middle-Aged Adults: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Dependent Clinical Trial. PMC10721522.
Healthline. Nicotinamide Riboside: Benefits, Side Effects, and Dosage. healthline.com/nutrition/nicotinamide-riboside.
Topol E. The Peptide Craze. Ground Truths Substack. July 2025.
Key takeaways
NAD+ is a coenzyme found in every cell, essential for energy metabolism and DNA repair. Levels decline with age. Oral NR and NMN raise blood NAD+ levels but the evidence for clinical outcomes in healthy adults is mixed. Injectable NAD+ has a stronger pharmacological argument for bioavailability but lacks its own large randomized trials. The honest framing is that the mechanism is real, the evidence is directional, and the value depends on physician-supervised use rather than DIY supplementation. Here is what we actually know.
A 2025 review in Nature Metabolism summarized the human clinical trial literature for NAD+ precursor supplementation in aging and concluded that despite robust preclinical signals, human trials have shown limited efficacy. That assessment landed because it was honest about something most NAD+ marketing was not. Raising a biomarker is not the same as improving health.
But the picture is more nuanced than that summary implies. The bioavailability difference between oral precursors and injectable NAD+ is real and matters clinically. Lumping them together obscures the actual question.
Here is what the evidence shows for each, where the honest gaps are, and how to think about NAD+ supplementation if you are evaluating it.
What NAD+ Is and Why It Matters
NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme — a small molecule that other proteins need to do their work. It is found in every cell of the body and is essential for three processes that matter for aging:
Energy metabolism. NAD+ is required for the chemical reactions that convert food into ATP, the molecule your cells use as energy.
DNA repair. The proteins that fix damaged DNA (particularly the PARP enzymes) use NAD+ as a substrate.
Sirtuin activation. The sirtuins are enzymes implicated in longevity pathways; they require NAD+ to function.
NAD+ levels decline with age. Studies in skeletal muscle and skin have reported tissue NAD+ concentrations 40–60% lower in older adults than in younger adults, though estimates vary by tissue and methodology. The plausible argument for supplementation is that restoring NAD+ levels could support the processes that depend on it. The honest question is whether raising blood NAD+ actually changes tissue NAD+, and whether tissue NAD+ changes translate into measurable clinical outcomes.
One small clarification worth making early: NAD+ is not a peptide, even though it is often marketed in the same category. It is a coenzyme. The distinction matters for how the evidence is interpreted.
Oral NR and NMN — What the Trials Actually Show
Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are the two most commonly used oral NAD+ precursors. Both raise blood NAD+ levels consistently in human trials. The clinical outcomes question is where the evidence gets thinner.
What has been shown in randomized trials:
Reliable increases in blood NAD+ levels at standard doses (300–1000 mg/day for NR; 250–1000 mg/day for NMN).
Modest improvements in measures of arterial stiffness in some studies — a marker of vascular aging.
Mixed evidence for cognitive function, physical performance, and recovery — some positive signals, some null results.
Generally good safety profile at studied doses.
What has not been clearly shown: large effects on the clinical outcomes that the marketing implies — energy, sleep, recovery, anti-aging measures. Individual response varies, and some users report meaningful changes while others report nothing.
The Nature Metabolism 2025 review was not wrong. The trial evidence for oral NR and NMN as anti-aging interventions in healthy adults is modest and directional, not conclusive. Anyone selling oral NAD+ precursors as proven anti-aging tools is overstating what the science currently supports. A simpler and cheaper option that also raises NAD+ is nicotinamide itself — worth knowing about even if it does not get the marketing attention.
Injectable NAD+ — The Pharmacology Argument
Injectable NAD+ — typically subcutaneous at 100–500 mg per dose, sometimes intravenous at 500–1500 mg per infusion — bypasses two limitations of oral supplementation. First, oral NAD+ precursors are subject to first-pass metabolism in the liver, where much of the compound is processed before reaching systemic circulation. Second, oral precursors require conversion to NAD+ inside cells, which happens efficiently in some tissues and less efficiently in others.
Direct subcutaneous NAD+ enters systemic circulation without requiring conversion in the gut or liver, though the specific pharmacokinetics in human tissue are still being characterized. Patient-reported outcomes in clinical practice tend to be more consistent than with oral preparations.
The honest limitation: injectable NAD+ does not have its own large randomized controlled trial database. The mechanism is plausible, the patient experience is often positive, and the safety profile in clinical use is good. Direct head-to-head trials comparing injectable NAD+ to oral NR/NMN to placebo for specific clinical outcomes do not exist at the scale we would like.
Cost is also worth being honest about. Oral NR/NMN supplements retail in the $30–60/month range. Physician-supervised injectable protocols are meaningfully more — typically several hundred dollars per month — which is worth weighing against the expected benefit.
How NAD+ and Glutathione Pair
NAD+ and L-glutathione are often used together in physician-supervised wellness protocols. The pairing is not arbitrary.
The mechanism is complementary. NAD+ supports the energy production happening in mitochondria. That energy production generates reactive oxygen species — free radicals — as a byproduct. Glutathione is the body's most important intracellular antioxidant, and it is what neutralizes those reactive oxygen species. Supporting energy production without supporting antioxidant defense leaves the mitochondria more exposed to oxidative damage.
There is no large trial proving the combination outperforms either alone. Clinically, the pairing is biologically coherent and widely used. We frame it that way to patients rather than overpromising synergy that has not been formally measured.
Side Effects and Practical Use
Both oral NR/NMN and injectable NAD+ are generally well tolerated.
Common with oral preparations: occasional GI upset, mild flushing at higher doses.
Common with injectable NAD+: mild injection site reactions, occasional flushing or mild nausea during or immediately after administration. IV administration at high doses can cause more pronounced flushing and chest tightness; subcutaneous administration at typical doses is considerably better tolerated.
Realistic expectations: most people who notice anything notice it gradually, over weeks. Anyone promising overnight transformation is selling marketing, not medicine.
How Leader Health Approaches This
At Leader Health, NAD+ supplementation is part of a physician-supervised wellness program — not a standalone purchase. We assess your baseline picture, set realistic expectations, monitor on a schedule, and pair NAD+ with the other tools (including L-glutathione) that mechanistically support what it is doing. If we do not think it is appropriate for you, we will say so.
If you have been considering NAD+ but are tired of marketing that overpromises, this is the conversation worth having.
References
Tan A, Mottillo EP, et al. NAD+ precursor supplementation in human ageing: a critical review of randomized clinical trials. Nat Metab. 2025. PMID: 41083806. nature.com/articles/s42255-025-01387-7.
Reiten OK, et al. Preclinical and clinical evidence for SIRT1 in the metabolism of aging — a critical review of NAD+ precursor supplementation. PMC10692436.
Yi L, et al. The Efficacy and Safety of β-Nicotinamide Mononucleotide (NMN) Supplementation in Healthy Middle-Aged Adults: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Dependent Clinical Trial. PMC10721522.
Healthline. Nicotinamide Riboside: Benefits, Side Effects, and Dosage. healthline.com/nutrition/nicotinamide-riboside.
Topol E. The Peptide Craze. Ground Truths Substack. July 2025.
In this article
Frequently Asked Questions
NAD+ is a coenzyme essential for energy metabolism, DNA repair, and sirtuin function. Every cell uses it. Levels decline with age, which is the rationale behind supplementation.
Pharmacologically, injectable NAD+ bypasses first-pass metabolism and delivers the molecule in its active form. Patient-reported outcomes are often more consistent. Head-to-head randomized trials directly comparing the two for specific clinical outcomes do not exist at scale, so the honest answer is pharmacology-supported, RCT-pending.
Yes, and they are often used together. The mechanism is complementary — NAD+ supports energy production; glutathione supports the antioxidant defense that protects the cells doing that work. There is no formal trial of the combination, but the pairing is biologically coherent.
Most people who notice changes notice them gradually over weeks. Some notice nothing at all. The lack of predictable, dramatic short-term effect is part of why NAD+ supplementation works best as part of a monitored wellness plan rather than as a standalone purchase.
No. Animal studies show NAD+ pathway activation can extend lifespan in model organisms. Human evidence for lifespan extension does not exist and probably cannot in the time horizon of a typical trial. We do not make lifespan claims; we describe what the mechanism plausibly supports.
NAD+ is generally well tolerated, but people with active cancer, severe kidney or liver disease, or significant cardiovascular instability should discuss it with a physician before starting. Pregnancy and lactation are also typical exclusions.
About Medical Reviewer
Stephen Ratcliff, MD
Stephen Ratcliff, MD
Stephen Ratcliff, MD
CMO of Leader Health
CMO of Leader Health
Stephen Ratcliff, MD is the Chief Medical Officer of Leader Health and the board-certified physician responsible for clinical governance, medical content review, and regulatory oversight across the platform. Every article on the Leader Health blog is reviewed and approved by Dr. Ratcliff before publication.
Stephen Ratcliff, MD is the Chief Medical Officer of Leader Health and the board-certified physician responsible for clinical governance, medical content review, and regulatory oversight across the platform. Every article on the Leader Health blog is reviewed and approved by Dr. Ratcliff before publication.
Stephen Ratcliff, MD is the Chief Medical Officer of Leader Health and the board-certified physician responsible for clinical governance, medical content review, and regulatory oversight across the platform. Every article on the Leader Health blog is reviewed and approved by Dr. Ratcliff before publication.
All related stories post
All related stories post
All related stories post
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.
What Every Woman Should Know About Hormone Replacement Therapy in Perimenopause — and Why Most Doctors Don't Tell You
What Every Woman Should Know About Hormone Replacement Therapy in Perimenopause — and Why Most Doctors Don't Tell You
Stephen Ratcliff, MD
Chief Medical Officer
Physician-authored guide to HRT in perimenopause: the WHI study corrected, delivery options, timing window, and what the current evidence actually supports.
Testosterone Replacement Therapy: A Physician's Evidence-Based Guide to TRT in 2026
Testosterone Replacement Therapy: A Physician's Evidence-Based Guide to TRT in 2026
Stephen Ratcliff, MD
Chief Medical Officer
Physician-led guide to TRT: when it's appropriate, lab workup, dosing protocols, monitoring, fertility considerations, and what stopping looks like.
Daily Low-Dose Tadalafil: What the Evidence Shows for Sexual and Cardiovascular Health
Daily Low-Dose Tadalafil: What the Evidence Shows for Sexual and Cardiovascular Health
Stephen Ratcliff, MD
Chief Medical Officer
Physician guide to daily low-dose tadalafil: how it works, who it's right for, the 2024 cardiovascular findings, and how it compares to as-needed use.
Science-led care for better living
Proven treatments for weight, hormones, and energy — without the guesswork. Just real, lasting results.
Science-led care for better living
Proven treatments for weight, hormones, and energy — without the guesswork. Just real, lasting results.
Science-led care for better living
Proven treatments for weight, hormones, and energy — without the guesswork. Just real, lasting results.
Backed by Science, Built for You Personalized, Trusted, Proven.
hello@leaderhealth.com
Men's HRT
Longevity
Quick Links
Backed by Science, Built for You Personalized, Trusted, Proven.
hello@leaderhealth.com
Men's HRT
Longevity
Quick Links
Backed by Science, Built for You Personalized, Trusted, Proven.
hello@leaderhealth.com
Men's HRT
Longevity
Quick Links